Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Terray Therapeutics logo — Everything small molecule drug discovery should be.

Terray Therapeutics

Everything small molecule drug discovery should be.

Founded 2018 United States Pasadena, United States 142 employees Series B Total: $195.00M AI, Biopharma +2

General Information

Company Name Terray Therapeutics
Founded Year 2018
Location United States Pasadena, United States
Employees 142
Industries AI, Biopharma, Biotechnology +1
Funding Stage Series B
Business Model B2B, Platform, SaaS
Revenue Model Service Fee, Performance Based, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Terray Therapeutics. To contact Terray Therapeutics, visit terraytx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Terray Therapeutics compare?

A PDF of Terray Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Terray Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Product Launch Sep 10, 2026

Terray Therapeutics developed TerraBind, the industry’s most efficient binding affinity and structure prediction model, available at the provided URL.

Get alerts when Terray Therapeutics shows new signals

About Terray Therapeutics

Terray Therapeutics, founded in 2018, is an innovative biotechnology company dedicated to transforming small molecule drug discovery. Their slogan, "Everything small molecule drug discovery should be.", encapsulates their commitment to revolutionizing this space.

The company leverages a powerful platform integrating ultra-high throughput experimentation, generative AI, biology, medicinal chemistry, automation, and nanotechnology. This approach generates massive, precise datasets that enhance value with each iteration, promising improvements in speed, cost, and success rates for drug discovery.

Based in the United States, Terray Therapeutics has attracted notable investors such as Madrona, Two Sigma Ventures, and Maverick Capital. The latest investment, a $120.00M Series B round in October 2024, underscores strong investor confidence in their pioneering approach.

Taxonomy: small molecule drug discovery, ultra-high throughput experimentation, generative AI, medicinal chemistry, nanotechnology, data-driven drug development, integrated machine learning, computational platform, biochemical interaction mapping, iterative design cycle, microarray technology, virtual molecular design, preclinical development

Services & Products

AI and experimental hardware development for drug discovery
Creating custom datasets for pharmaceutical research
Drug design and development for small molecules

Target Customers

Biotechnology companies Pharmaceutical firms Research institutions Healthcare organizations

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $120.00M 10
Madrona Two Sigma Ventures Goldcrest Capital
Madrona, Two Sigma Ventures +8
01 Oct 2024
Early VC Undisclosed 3
nVentures
nVentures, John Maraganore +1
01 Nov 2023
Series A $60.00M 9
Madrona Two Sigma Ventures KdT Ventures
Madrona, Two Sigma Ventures +7
01 Feb 2022
Seed $15.00M 2
Two Sigma Ventures Digitalis Ventures
Two Sigma Ventures, Digitalis Ventures
01 Jun 2021
Seed Undisclosed 1
Two Sigma Investments
01 Mar 2019

Latest News

View All
Biyoteknoloji girişimi Terray Therapeutics, 120 milyon dolar yatırım aldı — Webrazzi
Biyoteknoloji girişimi Terray Therapeutics, 120 milyon dolar yatırım aldı
Webrazzi Oct 18, 2024

Terray Therapeutics Alternatives & Competitors

View All Alternatives
Terray Therapeutics vs
iktos
iktos France

Artificial intelligence for new drug design

Series A
85 employees
AI, Biotechnology
Compare Terray Therapeutics vs iktos
Terray Therapeutics vs
Synnovation Therapeutics
Synnovation Therapeutics United States

A precision oncology company focused on small molecule therapies optimized to target key driver mech...

Series A
52 employees
Biotechnology, Health Care
Terray Therapeutics vs
Octant
Octant United States

Developing synthetic technology and applying next-generation DNA sequencing, gene synthesis, and gen...

Series B
69 employees
Biotechnology, Life Sciences
Also compare with: Terray Therapeutics vs Partex.AI Technology Partex.AI Technology View all alternatives

FAQ About Terray Therapeutics

Everything small molecule drug discovery should be.
Terray Therapeutics was founded in 2018.
Terray Therapeutics is headquartered in Pasadena, United States.
Terray Therapeutics operates in AI, Biopharma, Biotechnology and Life Sciences. Its work centres on small molecule drug discovery, ultra-high throughput experimentation, generative AI and medicinal chemistry. Its customers include Biotechnology companies, Pharmaceutical firms and Research institutions.
Terray Therapeutics has a B2B, Platform and SaaS business model. Its revenue comes from Service Fee, Performance Based and Licensing.
Terray Therapeutics has approximately 142 employees.
Terray Therapeutics has completed 5 funding rounds, raising a total of $195.00M. The latest funding stage is Series B.
Terray Therapeutics offers: AI and experimental hardware development for drug discovery, Creating custom datasets for pharmaceutical research, Drug design and development for small molecules.
Top alternatives and competitors to Terray Therapeutics include iktos, Synnovation Therapeutics, Octant, 1910 Genetics, A-Alpha Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Terray Therapeutics and iktos are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Terray Therapeutics, https://bouncewatch.com/company/terray-therapeutics, updated 25 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes